Clinical Trial Update: Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and pharmacokinetics of GS-9411 in healthy male volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• GS-9411

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED